Syncorn Pharmaceuticals is categorized under Drugs, Proprietaries, and Sundries in Columbia, SC and active since 2010.
Syncorn Pharmaceuticals was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Amelia M Mann at the company’s single location by writing to 1719 York Drive, Columbia, South Carolina SC 29204 or by phoning (803) 782-4691. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Syncorn Pharmaceuticals |
| Contact Person: | Amelia M Mann |
| Address: | 1719 York Drive, Columbia, South Carolina 29204 |
| Phone Number: | (803) 782-4691 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drugs, Proprietaries, and Sundries |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Syncorn Pharmaceuticals was started in 2010 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Amelia M Mann for inquiries that concern Syncorn Pharmaceuticals by calling the company number (803) 782-4691, as your correspondence is most welcome. Additionally, the physical location of the single location of Syncorn Pharmaceuticals can be found at the coordinates 34.016351,-81.000375 as well as the street address 1719 York Drive in Columbia, South Carolina 29204.
For its online presence, you may visit Syncorn Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.